Saturday, March 13, 2010 5:01:53 PM
I also wouldn't be surprised to see the PR come on Thursday or Friday given this is a re-submission.
Assuming it gets approved, I'm thinking $6-10 is probably a reasonable target out of the shoot. If a partnering deal follows immediately I think we could see $15-20 in short order. If not, price will probably pull back to the $5-6 range.
I think I read where the worldwide insomnia drug market is somewhere around $6.4B and the U.S. is 75% of the market. If Silenor could get 10% of the market with the right partner, a reasonable market cap would be around $500M (which is where I get the $20 target).
All MHO but I'm in for the ride, as I think this gets approved, and the biggest move doesn't come until the partnering deal is announced.
GLTA,
Murocman
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM